Voloridge Investment Management
KITE

Voloridge Investment Management’s Kite Pharma, Inc. KITE Stock Holding History

Voloridge Investment Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-175,294
Closed -$31.5M – 665
2017
Q3 		$31.5M Buy
175,294
+8,451
+5% +$1.18M 0.7% 30
2017
Q2 		$17.3M Buy
166,843
+6,595
+4% +$538K 0.43% 57
2017
Q1 		$12.6M Buy
+160,248
New +$9.91M 0.31% 87

Voloridge Investment Management's KITE Position: Q4 2017 in Review

Voloridge Investment Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 175,294 shares — an estimated $31.5M sold.

Voloridge Investment Management first reported a position in KITE in Q1 2017 and held it in 3 quarters. The position peaked at $31.5M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Voloridge Investment Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Voloridge Investment Management sold 175,294 Kite Pharma, Inc. shares in Q4 2017, an estimated $31.5M.
  • Voloridge Investment Management first reported a position in Kite Pharma, Inc. in Q1 2017 and held it in 3 quarters.
  • Voloridge Investment Management's Kite Pharma, Inc. position peaked at $31.5M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Voloridge Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.